Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil

Acta Tropica

Volumn 72, Issue 1, 1999, Pages 13-24

  Soares, Irene S ^a,b   Oliveira, Salma G ^c   Souza, José M ^c   Rodrigues, Mauricio M ^b  

^a Faculty of Geophysics   (Brazil)

^b Departamento de Microbiologia   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Malaria; Merozoite; P. vivax

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; BRAZIL; CHILD; FEMALE; HUMAN; MALARIA; MALE; MEROZOITE; PLASMODIUM VIVAX; POPULATION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREVALENCE; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032940604     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(98)00078-3     Document Type: Article

References (22)

1. Andrade A.L., Martelli C.M., Oliveira R.M., Arias J.R., Zicker F., Pang L. High prevalence of asymptomatic malaria in gold mining areas in Brazil. Clin. Infect. Dis. 20:1995;475.
2. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisid-dhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1990;1633-1641.
3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principles of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Camargo L.M.A., Dal Colletto G.M.D, Ferreira M.U., Gurgel S.M., Escobar A.L., Marques A., Krieger H., Camargo E.P., Pereira da Silva L.H. Hypoendemic malaria in Rondonia (Brazil, Western Amazon Region): seasonal variation and risk groups in an urban locality. Am. J. Trop. Med. Hyg. 55:1996;32-38.
5. Chang S. P., Case S. E., Gosnell W.L., Hashimoto A., Kramer K.J., Tam L.Q., Hashiro C.Q., Nikaido C.M., Gibson H.L., Lee-Ng C.T, Barr P.J., Yokota B.T., Hui G.S.N. A recombinant baculovirus 42-Kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:1996;253-261.
6. Daly T.M., Long C.A. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii 17XL merozoite surface protein-1 induces a protective immune response in mice. Infect. Immun. 61:1993;2462-2467.
7. Daly T.M., Long C.A. The humoral immune response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:1995;236-243.
8. del Portillo H.A., Longacre S., Khouri E., David P. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between Plasmodium species. Proc. Natl. Acad. Sci. USA. 88:1991;4030-4034.
9. Fraser T., Michon P., Barnwell J. W., Noe A. R., Al-Yaman F., Kaslow D. C., Adams J. H. Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy Binding Protein. Infect. Immun. 65:1997;2772-2777.
10. Galinski M.R., Barnwell J.W. Plasmodium vivax: merozoites invasion of reticulocytes and considerations for malaria vaccine development. Parasitol. Today. 12:1996;20-29.
11. Holder A.A., Riley E.M. Human immune response to MSP-1. Parasitol. Today. 12:1996;173-174.
12. Kumar S., Yadava A., Keister D.B., Tian J.H., Ohl M., Perdue-Greenfield K.A., Miller L.H., Kaslow D.C. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:1995;325-332.
13. Levitus G., Mertens F., Sperança M. A., Camargo L. M. A, . Ferreira M. U., del Portillo H. A. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax. Am. J. Trop. Med. Hyg. 51:1994;68-76.
14. Ling I.T., Ogun S.A., Holder A.A. Immunisation against malaria with a recombinant protein. Parasite Immunol. 16:1994;63-67.
15. Maitland K., Williams T.N., Newbold C.I. Plasmodium vivax and P. falciparum: Biological interactions and the possibility of cross-species immunity. Parasitol. Today. 13:1997;227-231.
16. Marques A.C. Human migration and the spread of malaria in Brazil. Parasitol. Today. 3:1987;166-170.
17. Nussenzweig R.S., Long C.A. Malaria vaccines: multiple targets. Science. 265:1994;1381-1383.
18. Prata A., Urdaneta M., McGrevy P.B., Tada M.S. Infrequency of asymptomatic malaria in an endemic area in Amazonas, Brazil. Ver. Soc. Bras. Med. Trop. 23:1988;51-54.
19. Soares I.S., Levitus G., Souza J.M., Del Portillo H.A., Rodrigues M.M. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect. Immun. 65:1997;1606-1614.
20. Soares, I.S., Barnwell, J.W., Ferreira, M.U., Laurino, J., Castilho, B.A., Rodrigues, M.M. Plasmodium vivax vaccine candidate displays limited allelic polymorphism, which does not restrict recognition by antibodies (manuscript in preparation).
21. Tian J.H., Kumar S., Kaslow D.C., Miller L.H. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect. Immun. 65:1997;3032-3036.
22. von der Weid T., Honavar N., Langhorne J. Gene-target mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol. 156:1996;2510-2516.